BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer

• Tomohiro Kubo

• Yutaka Kawano

• Nobuaki Himuro

• Shintaro Sugita

• Yasushi Sato

• Kazuma Ishikawa

• Kohichi Takada

• Kazuyuki Murase

• Koji Miyanishi

• Tsutomu Sato

• Rishu Takimoto

• Masayoshi Kobune

• Takayuki Nobuoka

• Koichi Hirata

• Tetsuji Takayama

• Mitsuru Mori

• Tadashi Hasegawa

• Junji Kato

Journal

• Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association / International Gastric Cancer Association, Japanese Gastric Cancer Association [編]

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association / International Gastric Cancer Association, Japanese Gastric Cancer Association [編] 19 (3), 827-838, 2016

  Tokyo : Springer Japan

Keywords

• BH3
• BAK
• Gastric cancer
• Docetaxel

Details

• CRID: 1523669554784074240
• NII Article ID: 40020881713
• NII Book ID: AA11316227
• ISSN: 14363291
• NDL BIB ID: 027487495
• Web Site: https://ndlsearch.ndl.go.jp/books/R000000004-I027487495
• Web Site: https://search.jamas.or.jp/link/ui/2017171943
• Text Lang: en
• NDL Source Classification:
  • ZS34(科学技術--医学--腫瘍・癌)
• Data Source:
  • NDL
  • CiNii Articles